Premier Alternatives

Cyclarity Therapeutics

Novato, CA · Founded 2019 · Privately Held (backing)

Developer of compound-based drugs designed to treat the underlying causes of age-related diseases. Cyclarity Therapeutics is based in Novato, CA and was founded in 2019. It was valued at $34.3 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $34 million across 1 recorded round; the latest was a $10.3 million early-stage round in Dec 2024.

PMV mark · valuation
$34.3M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$34.0M
Last round
Early Stage VC
Dec 2024

Cyclarity Therapeutics key facts

as of Oct 2026
  • Developer of compound-based drugs designed to treat the underlying causes of age-related diseases.
  • Cyclarity Therapeutics is valued at approximately $34.3M as of Oct 2026, set at its later-stage round, Dec 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $34.0M across 1 recorded rounds; the latest was Early Stage VC ($10.3M) in Dec 2024.
  • Notable investors include National Institutes of Health, Formic Ventures, Starbloom Capital, Ki Tua Fund, California Life Sciences — 12 tracked in total.
  • Cyclarity Therapeutics has filed 1 Form D with the SEC, most recently Dec 2024 ($10.3M sold to 19 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$34.3M

Valued at $34.3M at its later-stage round, Dec 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Private Market View
More of Cyclarity Therapeutics with a free Private Market View account
  • ·The complete investor list: 12 names
  • ·Watch Cyclarity Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Cyclarity Therapeutics funding rounds

1 rounds
Dec 2024Early Stage VC$10.3MSEC filing▮
Full funding history →

Cyclarity Therapeutics valuation

Cyclarity Therapeutics was valued at $34.3 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Cyclarity Therapeutics raised?

Cyclarity Therapeutics has raised $34 million in total; 1 of its rounds is on record. The largest on record was a $10.3 million early-stage round in Dec 2024.

Cyclarity Therapeutics has filed 1 Form D with the SEC, most recently in Dec 2024 ($10.3 million sold to 19 investors).

Cyclarity Therapeutics investors

12 investors are on record for Cyclarity Therapeutics, including National Institutes of Health, Formic Ventures, Starbloom Capital and Ki Tua Fund. The early-stage round in Dec 2024 drew 19 investors.

About Cyclarity Therapeutics

Developer of compound-based drugs designed to treat the underlying causes of age-related diseases. The company's drugs offer simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules to remove arterial plaque by clearing the non-degradable cholesterol, enabling clinicians to provide patients with disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.

Sector
Healthcare
HQ
Novato, CA, United States
Founded
2019
Employees
11
Ownership
Privately Held (backing)

Is this your company? Profiles are maintained at PrivateMarketView, the data platform behind this page — sign in with your work email to keep it current, or tell us what's wrong.